BRIEF-Mind Medicine Announces Q1 Results
- ByReuters-
May 14 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :* MIND MEDICINE (MINDMED) INC - CASH BALANCE OF $160M ($194M CAD) TO EXECUTE ON DIVERSE CLINICAL PIPELINE* MIND MEDICINE...
May 14 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :* MIND MEDICINE (MINDMED) INC - CASH BALANCE OF $160M ($194M CAD) TO EXECUTE ON DIVERSE CLINICAL PIPELINE* MIND MEDICINE...
April 23 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :* MINDMED TO COMMENCE TRADING ON NASDAQ* MINDMED - TRADING IS EXPECTED TO BEGIN ON APRIL 27, 2021, UNDER SYMBOL "MNMD"...
March 30 (Reuters) - Mind Medicine (MindMed) Inc MMED.NLB :* MINDMED ANNOUNCES FILING OF PRELIMINARY BASE SHELF PROSPECTUS AND F-10 WITH THE SEC UNDER MJDS
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Buy | Sell | Strong Sell | Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Neutral |
| Summary | Strong Buy | Strong Buy | Strong Sell | Strong Sell | Neutral |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 136.92 | 137.88 | 136.74 | -0.45 | -0.33% | 163.69K | Toronto | |||
| 1.91 | 1.92 | 1.79 | +0.140 | +7.91% | 290.77K | CSE | |||
| 9.39 | 9.59 | 9.31 | -0.02 | -0.21% | 14.32K | TSXV | |||
| 5.68 | 5.69 | 5.64 | +0.02 | +0.35% | 29.92K | Toronto | |||
| 0.27 | 0.00 | 0.00 | -0.0200 | -6.90% | 2.00K | CSE | |||
| 11.49 | 11.52 | 11.06 | +0.1300 | +1.14% | 66.26K | Toronto | |||
| 59.35 | 61.73 | 59.11 | -1.83 | -2.99% | 173.82K | Toronto | |||
| 2.36 | 2.39 | 2.26 | +0.020 | +0.85% | 370.61K | TSXV | |||
| 2.03 | 2.04 | 1.98 | -0.010 | -0.49% | 5.63M | Toronto | |||
| 120.19 | 121.50 | 118.05 | +2.14 | +1.81% | 356.65K | Toronto | |||
| 0.45 | 0.00 | 0.00 | +0.0500 | +12.50% | 110.46K | TSXV | |||
| 7.29 | 7.29 | 7.15 | +0.14 | +1.96% | 351.46K | Toronto | |||
| 24.41 | 24.44 | 24.34 | +0.08 | +0.33% | 1.30K | Toronto | |||
| 0.09 | 0.00 | 0.00 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 0.05 | 0.00 | 0.00 | 0.000 | 0.00% | 77.00K | TSXV |
Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.